About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Statins for Prevention of Contrast Induced Nephropathy

NCT00770796·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ospedale Misericordia e Dolce

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

patients with pre-angiographic estimated creatinine clearance \< 60 ml/min

You may not be if

contrast medium administration within the previous 10 days
end-stage renal failure requiring dialysis
refusal to give informed consent
previous therapy with statin

The record

StatusCompleted

PhasePhase 4

Taking part304

StartedApr 2006

UpdatedOct 16, 2015

Conditions

Contrast Induced Nephropathy

Clareo Health | Statins for Prevention of Contrast Induced Nephropathy